Factors affecting the choice of first-line therapy in Parkinson's disease patients in Wales: A population-based study

• Príomhchruthaitheoirí: Khalid Orayj (Údar), Ashley Akbari (Údar), Arron Lacey (Údar), Mathew Smith (Údar), Owen Pickrell (Údar), Emma L. Lane (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Elsevier, 2021-02-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

First line treatment for Parkinson's disease (PD) is typically either L-dopa or a non-ergot dopamine agonist (DA). However, the options for the treatment of motor symptoms in PD patients have increased in the last thirty years, which have seen several new classes of PD medications introduced on...